Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of AIM ImmunoTech Inc (AMEX: AIM) was $0.22 for the day, down -11.75% from the previous closing price of $0.25. In other words, the price has decreased by -$11.75 from its previous closing price. On the day, 0.84 million shares were traded. AIM stock price reached its highest trading level at $0.251 during the session, while it also had its lowest trading level at $0.2206.
Ratios:
Our analysis of AIM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.75. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 0.20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 16 ’24 when Equels Thomas K bought 5,000 shares for $0.30 per share. The transaction valued at 1,515 led to the insider holds 1,493,042 shares of the business.
Equels Thomas K bought 20,000 shares of AIM for $6,160 on Sep 13 ’24. The CEO & President now owns 1,488,042 shares after completing the transaction at $0.31 per share. On May 06 ’24, another insider, Equels Thomas K, who serves as the CEO & President of the company, bought 61,729 shares for $0.41 each. As a result, the insider paid 25,000 and bolstered with 778,184 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AIM now has a Market Capitalization of 14206528 and an Enterprise Value of 6039479. For the stock, the TTM Price-to-Sale (P/S) ratio is 66.00 while its Price-to-Book (P/B) ratio in mrq is 4.49. Its current Enterprise Value per Revenue stands at 30.047 whereas that against EBITDA is -0.193.
Stock Price History:
Over the past 52 weeks, AIM has reached a high of $0.62, while it has fallen to a 52-week low of $0.21. The 50-Day Moving Average of the stock is -16.07%, while the 200-Day Moving Average is calculated to be -38.47%.
Shares Statistics:
AIM traded an average of 301.14K shares per day over the past three months and 311260 shares per day over the past ten days. A total of 63.71M shares are outstanding, with a floating share count of 58.21M. Insiders hold about 8.62% of the company’s shares, while institutions hold 14.08% stake in the company. Shares short for AIM as of 1730332800 were 491374 with a Short Ratio of 1.63, compared to 1727654400 on 590329. Therefore, it implies a Short% of Shares Outstanding of 491374 and a Short% of Float of 0.8500000000000001.
